The main difference between these studies is that in those where the BDNF levels were lower in sarcopenic patients, the patients suffered from other diseases than sarcopenia and had poorer cognitive status, whereas in Pratt et al.’s study, the patients suffered only from sarcopenia and did not have problems with cognitive function. This evidence concerns the gene BDNF and sarcopenia.